LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 10.16 | 21.74 | 1025 | 463 | 2.2108 | 1.3937 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 10.16 | 21.74 | 4 | 463 | 0.0086 | -0.3185 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 10.16 | 21.74 | 1004 | 463 | 2.1655 | 1.3825 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.13 | 21.74 | 83 | 496 | 0.1672 | 0.3456 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.13 | 21.74 | 1045 | 496 | 2.1053 | 1.3587 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.13 | 21.74 | 30 | 496 | 0.0604 | 0.0740 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 12.13 | 21.74 | 1043 | 496 | 2.1013 | 1.3577 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 14.10 | 21.74 | 110 | 540 | 0.2034 | 0.4186 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 14.10 | 21.74 | 1066 | 540 | 1.9707 | 1.3151 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 14.10 | 21.74 | 86 | 540 | 0.1590 | 0.3452 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 14.10 | 21.74 | 1083 | 540 | 2.0021 | 1.3230 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 16.07 | 21.74 | 185 | 597 | 0.3094 | 0.5649 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 16.07 | 21.74 | 1113 | 597 | 1.8616 | 1.2776 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 16.07 | 21.74 | 204 | 597 | 0.3412 | 0.5972 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 16.07 | 21.74 | 1120 | 597 | 1.8734 | 1.2806 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 18.04 | 21.74 | 612 | 750 | 0.8154 | 0.9217 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 18.04 | 21.74 | 1148 | 750 | 1.5295 | 1.1734 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 18.04 | 21.74 | 569 | 750 | 0.7581 | 0.8945 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 18.04 | 21.74 | 1153 | 750 | 1.5362 | 1.1753 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 20.01 | 21.74 | 972 | 901 | 1.0777 | 1.0280 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 20.01 | 21.74 | 1188 | 901 | 1.3172 | 1.1052 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 20.01 | 21.74 | 825 | 901 | 0.9147 | 0.9671 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 20.01 | 21.74 | 1187 | 901 | 1.3161 | 1.1049 | MN20160310_N01 | L05 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 21.98 | 21.74 | 1094 | 1108 | 0.9871 | 0.9954 | MN20160310_N01 | L03 |
MCF 10A-H2B-mCherry | Trametinib | 0.1 | 21.98 | 21.74 | 1190 | 1108 | 1.0737 | 1.0252 | MN20160310_N01 | L03 |